Restoring Angiotensin Type 2 Receptor Function Reverses PFOS-Induced Vascular Hyper-Reactivity and Hypertension in Pregnancy
International Journal of Molecular Sciences · 16.09.2023 · 24 (18) · 14180
DOI: 10.3390/ijms241814180 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.09.2023. Verfasst von Sri Vidya Dangudubiyyam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA. Hauptthemen laut MEDLINE: Drinking Water, Hypertension, Pregnancy-Induced. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Perfluorooctane sulfonic acid (PFOS) exposure during pregnancy induces hypertension with decreased vasodilatory angiotensin type-2 receptor (AT2R) expression and impaired vascular reactivity and fetal weights. We hypothesized that AT2R activation restores the AT1R/AT2R balance and reverses gestational hypertension by improving vascular mechanisms. Pregnant Sprague-Dawley rats were exposed to PFOS through drinking water (50 μg/mL) from gestation day (GD) 4–20. Controls received drinking water with no detectable PFOS. Control and PFOS-exposed rats were treated with AT2R agonist Compound 21 (C21; 0.3 mg/kg/day, SC) from GD 15–20. In PFOS dams, blood pressure was higher, blood flow in the uterine artery was reduced, and C21 reversed these to control levels. C21 mitigated the heightened contraction response to Ang II and enhanced endothelium-dependent vasorelaxation in uterine arteries of PFOS dams. The observed vascular effects of C21 were correlated with reduced AT1R levels and increased AT2R and eNOS protein levels. C21 also increased plasma bradykinin production in PFOS dams and attenuated the fetoplacental growth restriction. These data suggest that C21 improves the PFOS-induced maternal vascular dysfunction and blood flow to the fetoplacental unit, providing preclinical evidence to support that AT2R activation may be an important target for preventing or treating PFOS-induced adverse maternal and fetal outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA.
- Endocrinology-Reproductive Physiology Program, University of Wisconsin, Madison, WI 53715, USA.
- Department of Obstetrics and Gynecology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53792, USA.
ORCID-Profile: Jay S Mishra, Sathish Kumar
Förderung
- NIEHS NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
- National Institute of Health (NIH)
Zitieren
APA
Dangudubiyyam, S. V., Bosse, B., Yadav, P., Song, R., Hofmann, A., Mishra, J. S., & Kumar, S. (2023). Restoring Angiotensin Type 2 Receptor Function Reverses PFOS-Induced Vascular Hyper-Reactivity and Hypertension in Pregnancy. International Journal of Molecular Sciences, 24(18), 14180. https://doi.org/10.3390/ijms241814180
Vancouver
Dangudubiyyam SV, Bosse B, Yadav P, Song R, Hofmann A, Mishra JS, et al. Restoring Angiotensin Type 2 Receptor Function Reverses PFOS-Induced Vascular Hyper-Reactivity and Hypertension in Pregnancy. International Journal of Molecular Sciences. 2023;24(18):14180. doi:10.3390/ijms241814180
BibTeX
@article{Dangudubiyyam2023,
author = {Dangudubiyyam, Sri Vidya and Bosse, Bradley and Yadav, Pankaj and Song, Ruolin and Hofmann, Alissa and Mishra, Jay S and Kumar, Sathish},
title = {Restoring Angiotensin Type 2 Receptor Function Reverses PFOS-Induced Vascular Hyper-Reactivity and Hypertension in Pregnancy},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {18},
pages = {14180},
doi = {10.3390/ijms241814180}
}
EUVIMED